| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...869762A |
| P356 | DOI | 10.1371/JOURNAL.PONE.0069762 |
| P932 | PMC publication ID | 3731299 |
| P698 | PubMed publication ID | 23936350 |
| P5875 | ResearchGate publication ID | 255737566 |
| P50 | author | Massimo Coletta | Q28359644 |
| Loris Leboffe | Q57131132 | ||
| Viviana Trezza | Q89397678 | ||
| Gabriella Fanali | Q114725521 | ||
| Mauro Fasano | Q37836911 | ||
| Andrea Coletta | Q43076330 | ||
| P2093 | author name string | Yu Cao | |
| Alessandra Pesce | |||
| Paolo Ascenzi | |||
| Chiara Ciaccio | |||
| Stefano Marini | |||
| P2860 | cites work | Advancing the development of tuberculosis therapy | Q22251041 |
| Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A | Q24550617 | ||
| Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis | Q24564370 | ||
| An oxyferrous heme/protein-based radical intermediate is catalytically competent in the catalase reaction of Mycobacterium tuberculosis catalase-peroxidase (KatG) | Q24644161 | ||
| Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria | Q24646505 | ||
| Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin | Q24652314 | ||
| Mycobacterium tuberculosis hemoglobin N displays a protein tunnel suited for O2 diffusion to the heme | Q27633806 | ||
| Human brain neuroglobin structure reveals a distinct mode of controlling oxygen affinity | Q27641983 | ||
| The tuberculosis prodrug isoniazid bound to activating peroxidases | Q27649209 | ||
| Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases: BINDING STUDIES AND CRYSTAL STRUCTURE OF BOVINE LACTOPEROXIDASE WITH ISONIAZID AT 2.7 A RESOLUTION | Q27658143 | ||
| X-ray crystal structure of the ferric sperm whale myoglobin: imidazole complex at 2.0 A resolution | Q27658337 | ||
| UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
| Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes | Q28204112 | ||
| Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today | Q28244912 | ||
| Crystal structure of cytoglobin: the fourth globin type discovered in man displays heme hexa-coordination | Q28257445 | ||
| The structure of murine neuroglobin: Novel pathways for ligand migration and binding | Q28263368 | ||
| NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis | Q28379488 | ||
| Molden: a pre- and post-processing program for molecular and electronic structures. | Q50694018 | ||
| Characterization of the binding of isoniazid and analogues to Mycobacterium tuberculosis catalase-peroxidase. | Q52577134 | ||
| Cardiolipin modulates allosterically peroxynitrite detoxification by horse heart cytochrome c | Q52605434 | ||
| Peroxynitrite detoxification by horse heart carboxymethylated cytochrome c is allosterically modulated by cardiolipin. | Q52617985 | ||
| Studies on the Equilibria and Kinetics of the Reactions of Peroxidases with Ligands. III. The Dissociation of Carbon Monoxide from Carbon Monoxide Ferro-Horseradish Peroxidase* | Q52756166 | ||
| Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors. | Q55045695 | ||
| General atomic and molecular electronic structure system | Q56017006 | ||
| Tuberculosis | Q56395930 | ||
| Isoniazid (I.N.H.) in the treatment of depressive syndrome: a pilot trial | Q66904594 | ||
| Isoniazid-associated psychosis | Q79451835 | ||
| Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin | Q83125213 | ||
| Isoniazid-induced psychosis | Q85056063 | ||
| Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin | Q85075300 | ||
| Mycobacterial subversion of chemotherapeutic reagents and host defense tactics: challenges in tuberculosis drug development | Q37413323 | ||
| Nervous system effects of antituberculosis therapy | Q37775611 | ||
| Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis | Q37783433 | ||
| Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs | Q37874018 | ||
| New tuberculosis drugs on the horizon | Q37912808 | ||
| Developments in chemical approaches to treat tuberculosis in the last decade | Q37971957 | ||
| Prevention of drug resistance by combined drug treatment of tuberculosis | Q38054566 | ||
| Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo | Q39247405 | ||
| Molecular mechanisms of drug resistance in Mycobacterium tuberculosis | Q41114790 | ||
| Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. | Q41988192 | ||
| Novel flavohemoglobins of mycobacteria | Q42466093 | ||
| Drug binding to Sudlow's site I impairs allosterically human serum heme-albumin-catalyzed peroxynitrite detoxification. | Q42846284 | ||
| Metmyoglobin and methemoglobin catalyze the isomerization of peroxynitrite to nitrate | Q44667746 | ||
| Heme-ligand tunneling in group I truncated hemoglobins | Q44797053 | ||
| Mechanistic studies of the isomerization of peroxynitrite to nitrate catalyzed by distal histidine metmyoglobin mutants. | Q44919098 | ||
| Bishistidyl heme hexacoordination, a key structural property in Drosophila melanogaster hemoglobin | Q46510517 | ||
| Sensitive liquid chromatographic technique to measure isoniazid in alveolar cells, bronchoalveolar lavage and plasma in HIV-infected patients. | Q46650821 | ||
| Cyanide binding to truncated hemoglobins: a crystallographic and kinetic study | Q47660721 | ||
| Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review | Q28481845 | ||
| Nitric oxide scavenging and detoxification by the Mycobacterium tuberculosis haemoglobin, HbN in Escherichia coli | Q28486473 | ||
| Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide | Q28486863 | ||
| A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis | Q28487591 | ||
| Mechanisms of action of isoniazid | Q29026436 | ||
| AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility | Q29547658 | ||
| inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis | Q29617412 | ||
| Multidrug-resistant tuberculosis. | Q30344085 | ||
| Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms. | Q30366172 | ||
| A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite | Q31938170 | ||
| Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates | Q33982614 | ||
| Isoniazid-induced psychosis | Q34067577 | ||
| Microbial globins | Q34270115 | ||
| Isoniazid- and ethambutol-induced psychosis | Q34609409 | ||
| The challenge of new drug discovery for tuberculosis | Q34660424 | ||
| The discovery of antidepressants: a winding path | Q35016663 | ||
| Tuberculosis chemotherapy: current drug delivery approaches | Q35069271 | ||
| A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs | Q35242238 | ||
| Truncated hemoglobins and nitric oxide action | Q35622949 | ||
| Review: multidrug-resistant tuberculosis: public health challenges | Q35631580 | ||
| An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid. | Q35827548 | ||
| Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? | Q35849799 | ||
| Nitric oxide and nitrosative stress tolerance in bacteria | Q36018437 | ||
| Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis | Q36018737 | ||
| Drug resistance in tuberculosis | Q36026282 | ||
| Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment | Q36163221 | ||
| Management of active tuberculosis | Q36338558 | ||
| A kinetic description of ligand binding to sperm whale myoglobin | Q36477062 | ||
| Treatment of multidrug-resistant tuberculosis: evidence and controversies. | Q36560899 | ||
| From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis | Q36753317 | ||
| The clinical management of drug-resistant tuberculosis | Q36783348 | ||
| Leprosy and tuberculosis: an insight-review | Q36799510 | ||
| Scavenging of reactive nitrogen species by mycobacterial truncated hemoglobins | Q37073025 | ||
| Extensively drug-resistant tuberculosis: current challenges and threats | Q37163527 | ||
| Extensively drug-resistant tuberculosis | Q37319847 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| isoniazid | Q423169 | ||
| P304 | page(s) | e69762 | |
| P577 | publication date | 2013-08-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N | |
| P478 | volume | 8 |
| Q90331372 | Ferric nitrosylated myoglobin catalyzes peroxynitrite scavenging |
| Q59793345 | Human nitrobindin: the first example of an all-β-barrel ferric heme-protein that catalyzes peroxynitrite detoxification |
| Q46345215 | Hydroxylamine-induced oxidation of ferrous carbonylated truncated hemoglobins from Mycobacterium tuberculosis and Campylobacter jejuni is limited by carbon monoxide dissociation |
| Q28076859 | Isoniazid metabolism and hepatotoxicity |
| Q38208324 | Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress |
| Q21132054 | Nitrite-reductase and peroxynitrite isomerization activities of Methanosarcina acetivorans protoglobin |
| Q33933447 | Nitrosylation mechanisms of Mycobacterium tuberculosis and Campylobacter jejuni truncated hemoglobins N, O, and P. |
| Q46312784 | Peroxynitrite scavenging by Campylobacter jejuni truncated hemoglobin P. |
| Q48175634 | Regulation of Three Virulence Strategies of Mycobacterium tuberculosis: A Success Story |
| Q35140367 | The Mycobacterium tuberculosis Rv2745c plays an important role in responding to redox stress. |
| Q27702517 | The N-terminal pre-A region of Mycobacterium tuberculosis 2/2HbN promotes NO-dioxygenase activity |
Search more.